Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hematopoietic-specific microRNA expression in human cells.

Shakti H Ramkissoon1, Lori A Mainwaring, Yoji Ogasawara

  • 1Howard Hughes Medical Institute-National Institutes of Health Research Scholars Program, Bethesda, MD 20892, USA.

Leukemia Research
|October 18, 2005
PubMed
Summary

Hematopoietic microRNAs (miRNAs) showed similar patterns in malignant and normal cells, but expression levels differed significantly. These findings highlight the role of miRNAs in human hematopoietic diseases and oncogenesis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A motif-vocabulary model of CAR T-cell intracellular domains identifies determinants of immunophenotype differentiation.

bioRxiv : the preprint server for biology·2026
Same author

Activation and exhaustion of CD8 T cells in patients with chronic lymphocytic leukemia treated with ibrutinib and pembrolizumab.

Journal of immunology (Baltimore, Md. : 1950)·2025
Same author

Potentiating CD20 monoclonal antibody therapy by targeting complement C3 fragments covalently deposited on lymphoma cells.

Blood·2025
Same author

Galectin-1 is associated with hematopoietic cell engraftment in murine MHC-mismatched allotransplantation.

Frontiers in immunology·2024
Same author

Neutrophil Heterogeneity Is Modified during Acute Lung Inflammation in Apoa1-/- Mice.

Journal of immunology (Baltimore, Md. : 1950)·2024
Same author

Low dose post-transplant cyclophosphamide and sirolimus induce mixed chimerism with CTLA4-Ig or lymphocyte depletion in an MHC-mismatched murine allotransplantation model.

Bone marrow transplantation·2024

Area of Science:

  • Molecular Biology
  • Hematology
  • Oncology

Background:

  • MicroRNAs (miRNAs) are crucial regulators of gene expression.
  • Hematopoietic stem cells differentiate into various blood cell lineages.
  • Dysregulation of miRNA expression is implicated in various cancers, including hematologic malignancies.

Purpose of the Study:

  • To investigate the expression profiles of specific hematopoietic tissue-specific miRNAs in malignant hematopoietic cell lines.
  • To compare these profiles with those in normal human hematopoietic lineages.
  • To explore the potential role of miRNAs in human hematopoiesis and oncogenesis.

Main Methods:

  • Expression profiling of four key miRNAs (miR-142, miR-155, miR-181, miR-223) was performed.
  • Analysis included 17 commercially available malignant hematopoietic cell lines.

Related Experiment Videos

  • Comparison was made against highly purified normal human B, T, monocytic, and granulocytic cell lineages.

    • Main Results:

    • Malignant cell lines exhibited miRNA expression patterns resembling normal hematopoietic lineages.
    • Significant differences in miRNA expression levels were observed between cell lines and normal cells.
    • Distinct miRNA expression differences were noted between mouse and human hematopoietic cells.

    Conclusions:

    • MiRNA expression patterns are altered in malignant hematopoietic cells, suggesting their significance in hematopoietic diseases.
    • Differences in miRNA expression underscore their regulatory roles in human hematopoiesis and oncogenesis.
    • Human-specific miRNA regulatory mechanisms in hematopoiesis warrant further investigation.